Article

New painkiller approved for cancer patients

Author(s):

Today, the Food and Drug Administration approved a new painkiller called Onsolis. It's an absorbable film that you stick to the inside of your cheek and it delivers a potent dose of fentanyl. The FDA approved the opioid pain reliever specifically for breakthrough -- severe, but short-lived -- pain that patients experience despite round-the-clock use of other pain medications. There's also some pretty tough restrictions on getting access to Onsolis -- patients have to be counseled by phone before they receive the drug, which is then sent directly to the patient's home.Check out the approval and distribution details from the FDA.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.